Ledger.Open graph →
SEC Form D · filed February 15, 2019

Vaxess Technologies, Inc

Offering
$3.6M
Sold
$3.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jonathan Kluge · Cambridge, MAExecMichael Schrader · Cambridge, MAExec · DirectorKathryn Kosuda · Cambridge, MAExec · DirectorLivio Valenti · Cambridge, MAExecWendy E. Holley · St. Helier, Y9Exec · DirectorJonathan G. Shulkin · Chicago, ILExecKeith Manchester · Palo Alto, CAExec · DirectorMichael Blue · Seattle, WAExecAaron Sandoski · Arlington, MADirectorJames Connolly · Allston, MADirectorMark Tracy · Cambridge, MAExecJulia Hu · Mountain View, CAExec · DirectorChristina Mcguire · London, United KingdomExecHelen Wetherall · St Helier, Y9ExecAnthony R. Sozio · New York, NYExec · DirectorAaron Sandoski · Allston, MADirectorJames Connolly · Allston, MADirectorMark Tracy · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗